You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • P192 Functional respiratory imaging (fri) and lung function assessment of glycopyrronium/formoterol fumarate dihydrate fixed-dose combination delivered using innovative co-suspension delivery technology (gff mdi) in copd

Article info

Article menu

Download PDFPDF

Biomarkers, imaging and outcomes in COPD
P192 Functional respiratory imaging (fri) and lung function assessment of glycopyrronium/formoterol fumarate dihydrate fixed-dose combination delivered using innovative co-suspension delivery technology (gff mdi) in copd
Free

Authors

Citation

De Backer W, De Backer J, Vos W, et al
P192 Functional respiratory imaging (fri) and lung function assessment of glycopyrronium/formoterol fumarate dihydrate fixed-dose combination delivered using innovative co-suspension delivery technology (gff mdi) in copd
Thorax 2017;72:A186-A188.

Publication history

  • First published November 15, 2017.
Online issue publication 
September 01, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions